Table 1. Baseline characteristics of the patients.

	No	%
Age (median)	63 (36–87)
Male	84	61
Female	54	39
Performance Status
0	68	49
1	48	35
2	22	16
KRAS mutation status
Wild Type	88	64
Mutant Type	46	33
Undetermined	4	3
BRAF mutation status
Wild Type	123	89
Mutant Type	2	2
Undetermined	13	9
PI3KCA mutation status
Wild Type	105	76
Mutant Type	20	15
Undetermined	13	9

(N = 138).